- Home
- ARQT vs VTEX Comparison
ARQT vs VTEX Comparison
Compare ARQT & VTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | VTEX |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 710.7M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARQT | VTEX |
|---|---|---|
| Price | $28.33 | $3.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $24.83 | $6.96 |
| AVG Volume (30 Days) | ★ 1.8M | 813.9K |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.40 |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $317,929,000.00 | $234,115,000.00 |
| Revenue This Year | $85.51 | $9.00 |
| Revenue Next Year | $30.74 | $13.06 |
| P/E Ratio | ★ N/A | $53.20 |
| Revenue Growth | ★ 129.21 | 3.65 |
| 52 Week Low | $11.13 | $3.65 |
| 52 Week High | $31.77 | $6.93 |
Technical Indicators
Market Signals| Indicator | ARQT | VTEX |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 36.81 |
| Support Level | $27.55 | $3.69 |
| Resistance Level | $30.26 | $3.77 |
| Average True Range (ATR) | 1.03 | 0.09 |
| MACD | -0.31 | -0.00 |
| Stochastic Oscillator | 23.92 | 15.00 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About VTEX VTEX
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.